From the CMS doc “Medicare Drug Worth Negotiation Program: Chosen Medication for Preliminary Worth
Applicability 12 months 2027“:
On January 17, 2025, CMS introduced the number of the under checklist of 15 medication lined underneath Medicare Half D for the second cycle of negotiations (preliminary worth applicability yr 2027), primarily based on whole gross lined prescription drug prices underneath Medicare Half D and different standards as required by the regulation.
With the Trump inauguration to happen on Monday, will the Medicare Drug Worth Negotiation course of change with the brand new administration? Anna Kaltenboeck notes in EndPoints Information:
…the following administration won’t have “blanket authority to vary the core components of the regulation,” sure points of the method could be modified with out legislative motion.
For instance, CMS may alter its steerage or the way it interprets components of the regulation, equivalent to what number of occasions it meets with drugmakers, or what number of listening classes it holds. “The diploma to which they play hardball with producers within the course of may change,” she mentioned.
